During the recent session, Theriva Biologics Inc (AMEX:TOVX)’s traded shares were 2.8 million, with the beta value of the company hitting 1.38. At the last check today, the stock’s price was $3.86, reflecting an intraday gain of 10.29% or $0.36. The 52-week high for the TOVX share is $17.11, that puts it down -343.26 from that peak though still a striking 31.09% gain since the share price plummeted to a 52-week low of $2.66. The company’s market capitalization is $3.90M, and the average intraday trading volume over the past 10 days was 0.19 million shares, and the average trade volume was 48.76K shares over the past three months.
Theriva Biologics Inc (AMEX:TOVX) trade information
Theriva Biologics Inc (TOVX) registered a 10.29% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 10.29% in intraday trading to $3.86, hitting a weekly high. The stock’s 5-day price performance is 18.68%, and it has moved by -33.88% in 30 days. Based on these gigs, the overall price performance for the year is -69.43%. The short interest in Theriva Biologics Inc (AMEX:TOVX) is 3988.0 shares and it means that shorts have 0.19 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 51.06%. While earnings are projected to return 7.02% in 2024.
TOVX Dividends
Theriva Biologics Inc is due to release its next quarterly earnings in September. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Theriva Biologics Inc (AMEX:TOVX)’s Major holders
Theriva Biologics Inc insiders own 1.32% of total outstanding shares while institutional holders control 5.52%, with the float percentage being 5.59%.
Also, the Mutual Funds coming in first place with the largest holdings of Theriva Biologics Inc (TOVX) shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund . Data provided on Mar 31, 2024 indicates that Vanguard Extended Market Index Fund owns about 7.78 shares. This amounts to just over 0.77 percent of the company’s overall shares, with a $30030.0 market value. The same data shows that the other fund manager holds slightly less at 3.6, or about 0.36% of the stock, which is worth about $13884.0.
